Both in Pharmaceuticals
uniQure vs Phibro Animal Health
Over the past year QURE returned −31.7% and PAHC returned −12.4%; their daily moves had a correlation of -0.07.
QURE −31.7% PAHC −12.4%Growth of $1, one year, split-adjusted
| Metric | QURE | PAHC |
|---|---|---|
| Price | $23.44 | $38.00 |
| Market cap | $1.63B | $1.54B |
| Today | +2.02% | −1.91% |
| 1 month | +2.8% | +2.2% |
| 6 months | +10.8% | −32.4% |
| Year to date | −2.1% | +1.7% |
| 1 year | −65.4% | −9.7% |
| Revenue growth (YoY) | +11.0% | +4.8% |
| Gross margin | 94.0% | 33.9% |
| Net margin | −1387.8% | 5.5% |
| P/E (TTM) | — | 15.5× |
| Price / sales | 87.1× | 1.0× |
| Net cash | $760.2M | -$650.8M |
| Dividend yield | — | 1.26% |
| Volatility (60d) | 108.8% | 29.8% |
| Short % of float | 13.2% | 4.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).